18F-Fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: A single-institution retrospective study

Dermatologic Surgery

Volumn 39, Issue 9, 2013, Pages 1323-1333

  Ibrahim, Sherrif F ^a   Ahronowitz, Iris ^b   McCalmont, Timothy H ^b   Hernandez Pampaloni, Miguel ^c   Ryan, Julie L ^a   Yu, Siegrid S ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MERKEL CELL TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84883556438     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12246     Document Type: Article

References (40)

1. Lemos BD, Storer BE, Iyer JG, Phillips JL, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751-61.
2. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126: 1514-9.
3. AJCC cancer staging manual (6th ed). Springer: Chicago, 2002; p. 315.
4. Allen PJ, Zhang ZF, Coit DG,. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229: 97-105.
5. Allen PJ, Bowne WB, Jaques DP, Brennan MF, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23: 2300-9.
6. Clark JR, Veness MJ, Gilbert R, O'Brien CJ, et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007; 29: 249-57.
7. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010; 37: 20-7.
8. Gupta SG, Wang LC, Peñas PF, Gellenthin M, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006; 142: 685-90.
9. Shaw JH, Rumball E,. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991; 78: 138-42.
10. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001; 8: 204-8.
11. Krug B, Crott R, Lonneux M, Baurain JF, et al. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology 2008; 249: 836-44.
12. Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM,. [18F] FDG PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J 2010; 86: 174-82.
13. Kumar R, Alavi A,. Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma. Curr Opin Oncol 2005; 17: 154-9.
14. Musto A, Rampin L, Nanni C, Marzola MC, et al. Present and future of PET and PET/CT in gynaecologic malignancies. Eur J Radiol 2011; 78: 12-20.
15. Concannon R, Larcos GS, Veness M,. The impact of (18) F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol 2010; 62: 76-84.
16. Larson SM, Schwartz LH,. 18F-FDG PET as a candidate for 'qualified biomarker': functional assessment of treatment response in oncology. J Nucl Med 2006; 47: 901-3.
17. Ell PJ,. The contribution of PET/CT to improved patient management. Br J Radiol 2006; 79: 32-6.
18. Peloschek P, Novotny C, Mueller-Mang C, Weber M, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010; 73: 317-23.
19. Talbot J-N, Kerrou K, Missoum F, Grahek D, et al. 6-[F-18] fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data. Mol Imaging Biol 2005; 7: 257-61.
20. Belhocine T, Pierard GE, Frühling J, Letesson G, et al. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep 2006; 16: 347-52.
21. Yao M, Smith RB, Hoffman HT, Funk GF, et al. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol 2005; 28: 205-10.
22. Lin O, Thomas A, Singh A, Greenspan B,. Complementary role of positron emission tomography in merkel cell carcinoma. South Med J 2004; 97: 1110-2.
23. Nguyen BD,. Positron emission tomographic imaging of Merkel cell carcinoma. Clin Nucl Med 2002; 27: 922-3.
24. Scanga DR, Martin WH, Delbeke D,. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med 2004; 29: 86-90.
25. Bedi C, Seel M, Ramdave S, Hicks R, et al. The use of FDG-PET Scanning (PET) in the Management of Merkel Cell Carcinoma. Int J Radiat Oncol Biol Phys 2008; 72: S107.
26. Iagaru A, Quon A, McDougall IR, Gambhir SS,. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18] fluoro-D-glucose-positron emission tomography/computed tomography? Mol Imaging Biol 2006; 8: 212-7.
27. Maury G, Dereure O, Du-Thanh A, Mariano-Goulart D, et al. Interest of (18) F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients. J Eur Acad Dermatol Venereol 2011; 25: 1420-7.
28. Colgan MB, Tarantola TI, Weaver AL, Wiseman GA, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol 2012; 67: 1250-6.
29. Gess AJ, Silkiss RZ,. A merkel cell carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg 2012; 28: e11-3.
30. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.
31. Mojica P, Smith D, Ellenhorn JDI,. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007; 25: 1043-7.
32. Hodgson NC,. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005; 89: 1-4.
33. Lanoy E, Costagliola D, Engels EA,. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 2010; 126: 1724-31.
34. Ziprin P, Smith S, Salerno G, Rosin RD,. Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia. Br J Dermatol 2000; 142: 525-8.
35. Warner RE, Quinn MJ, Hruby G, Scolyer RA, et al. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008; 15: 2509-18.
36. Schwartz JL, Griffith KA, Lowe L, Wong SL, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011; 29: 1036-41.
37. Golan H, Volkov O, Linchinsky O, Melloul M,. FDG-PET imaging in Merkel cell carcinoma-value of head-to-toe scan. Nucl Med Rev Cent East Eur 2005; 8: 135-6.
38. Nguyen BD, McCullough AE,. Imaging of Merkel cell carcinoma. Radiographics 2002; 22: 367-76.
39. Werner MK, Aschoff P, Reimold M, Pfannenberg C,. FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies. Br J Radiol 2011; 84: e65-7.
40. NCCN Clincial Practice Guidelines in Oncology (NCCN Guidelines). Merkel cell carcinoma. version 1. National Comprehensive Cancer Network, Inc.: Fort Washington, PA, 2012; p. MCC-1.